Ollin Biosciences
Biotechnology Research • 
Austin, Texas, United States • 11-20 Employees
Company overview
| Headquarters | Austin, Texas, United States |
| Website | |
| NAICS | 541714 |
| Employees | 11-20 |
Key Contacts at Ollin Biosciences
Jason Ehrlich
Chief Executive Officer
Steve Gill
Senior Director, Clinical Liaison
Jamie Spencer Christensen
Senior Director Clinical Operations
Nanette Podesta
Associate Director, Clinical Operations
Ollin Biosciences Email Formats
Ollin Biosciences uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@ollin.bio), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@ollin.bio | 100% |
About Ollin Biosciences
Ollin Biosciences is a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases. With a differentiated pipeline, world-class team, and strong investor syndicate, Ollin is redefining what’s possible in ophthalmology.
Ollin Biosciences revenue & valuation
| Annual revenue | $1,197,770 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,900,000 |
| Total funding | $100,000,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Ollin Biosciences has 3 employees across 3 departments.
Departments
Number of employees
Netherlands
Canada
Tanzania, United Republic of
FranceFrequently asked questions
4.8
40,000 users
